RxDoctor Payments Data

Evan Stathulis, MD

Family Medicine · Gahanna, OHNPI 1215904180

Payments from drug & device makers

$12,998in general payments, 2019–2025

Across 867 payments — averaging $14.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • AstraZeneca$1K
  • Johnson & Johnson$861
  • Lilly USA, LLC$753
  • Pfizer$721
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$12,990100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk132$1,810
AbbVie(2 entities)105$1,508
AstraZeneca(2 entities)73$1,197
Johnson & Johnson59$861
Lilly USA, LLC60$753
Pfizer57$721
Boehringer Ingelheim54$698
GSK37$595
Amarin Pharma, Inc.27$469
Amgen(2 entities)28$404
Sanofi-aventis U.S. LLC24$309
Takeda Pharmaceuticals U.S.A., Inc.18$296
Exact Sciences9$244
Merck21$227
Bayer12$216
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$198
Abbott11$190
Biohaven Pharmaceutical Holding Company Ltd.11$180
Teva Pharmaceuticals USA, Inc.10$141
Novartis8$141
Astellas Pharma US Inc6$119
Xeris Pharmaceuticals, Inc.5$114
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$108
Axsome Therapeutics, Inc.5$104
Phathom Pharmaceuticals, Inc.5$99
Genentech USA, Inc.5$76
Viiv Healthcare Company4$75
Eisai Inc.4$71
Esperion Therapeutics, Inc.4$70
Gilead4$69
Avvisto Therapeutics, LLC3$69
Edwards Lifesciences2$65
Dexcom, Inc.3$50
Coloplast1$46
Medtronic2$42
Nestle Healthcare Nutrition Inc.3$42
Kowa Pharmaceuticals America, Inc.3$37
Biohaven Pharmaceuticals, Inc.3$36
Corcept Therapeutics2$34
Exeltis, USA Inc.2$34
Neos Therapeutics, LP2$33
Collegium Pharmaceutical, Inc.2$33
Clarus Therapeutics Inc.2$32
Ultragenyx Pharmaceutical Inc.2$31
Mayne Pharma Commercial LLC1$26
Arbor Pharmaceuticals, Inc.2$25
Verona Pharma, Inc.1$20
Lundbeck LLC1$20
BD1$20
Jazz Pharmaceuticals Inc.1$19
ARS Pharmaceuticals Operations, Inc.1$19
Melinta Therapeutics, LLC1$18
ANI Pharmaceuticals, Inc.1$18
Inari Medical, Inc.1$17
Shield Therapeutics Inc1$17
Amneal Pharmaceuticals LLC1$16
E.r. Squibb & Sons, L.L.C.1$16
Radius Health, Inc.1$16
Promius Pharma LLC1$15
Sanofi Pasteur Inc.1$15

How this compares

$12,998 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$52,002
Medicare patients
157
Services billed
1,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin30$49,401
XareltoRivaroxaban35$39,048
EliquisApixaban47$35,989
FarxigaDapagliflozin Propanediol29$34,688
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$15,088
JanuviaSitagliptin Phosphate14$14,752
OzempicSemaglutide14$14,495
GlyxambiEmpagliflozin/Linagliptin15$14,152
LinzessLinaclotide16$12,509
ShingrixVaricella-Zoster Ge/As01b/Pf38$8,414
Atorvastatin Calcium349$3,724
Valsartan87$3,204
PaxlovidNirmatrelvir/Ritonavir11$2,858
Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide58$2,534
Tamsulosin Hcl88$2,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi$698$63,55345 claims
Johnson & JohnsonXarelto$861$39,04835 claims
PfizerEliquis, Paxlovid$721$38,84758 claims
AstraZenecaFarxiga$1,197$34,68829 claims
GSKTrelegy Ellipta, Shingrix$595$23,50349 claims
MerckJanuvia$227$14,75214 claims
Novo NordiskOzempic$1,810$14,49514 claims
AbbVieLinzess$1,508$12,50916 claims
ANI Pharmaceuticals, Inc.Valsartan$18$3,20487 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$64272 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Gahanna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →